Depocillina

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Depocillina

Property Description
Active ingredient Benzylpenicillin (Penicillin G) + Procaine
Form Aqueous Suspension for Injection
Pharmacological Class Beta-Lactam Antibiotic (Natural Penicillin)
General Purpose Treatment of systemic bacterial infections
Origin Semi-synthetic (derived from natural nucleus)

What Type of Antimicrobial is Depocillina?

Depocillina is a prescription-only injectable medicine identified generically as Procaine Benzylpenicillin, which functions as a systemic antibiotic. It belongs to the foundational pharmacological group of Beta-Lactam Antibiotics, specifically categorized as a Natural Penicillin. This medicine is authorized for veterinary use to combat bacterial infections caused by susceptible microorganisms, for its efficacy against many common pathogens. The active antimicrobial agent, Benzylpenicillin, provides an effective therapy against conditions like deep-seated soft tissue infections.


Composition and Long-Acting Formulation (Procaine Benzylpenicillin)

Depocillina is supplied as an aqueous suspension for injection, composed of the active agent Benzylpenicillin and the local anesthetic Procaine. This unique binding to Procaine is a differentiating factor compared to short-acting penicillin salts, as it renders the product long-acting. This structure ensures the slow, sustained release of the antibiotic into the bloodstream, maintaining therapeutic levels over an extended period. The design facilitates consistent antimicrobial presence and is classified as semi-synthetic, stemming from a naturally derived compound modified to enhance its action.


General Purpose and Mechanism of Action (Bactericidal)

The primary purpose of this product is to address infections caused by bacteria sensitive to penicillin.

The Benzylpenicillin component works by interfering with the vital process of bacterial cell wall synthesis. This mechanism results in the antibiotic being bactericidal, meaning it actively kills the microbial cells rather than merely inhibiting their growth. Therefore, the medicine's value lies in its direct, lethal action against susceptible pathogens, aiding the body in clearing the underlying bacterial infection.

Regulatory References

  1. WHO Model List of Essential Medicines
  2. NIH StatPearls: Penicillin

What side effects are possible with Depocillina?

Possible side effects and safety information

The safety profile of Procaine Benzylpenicillin (Depocillina) is officially structured around core risks tied to its components and administration. Regulatory documents classify potential adverse reactions by frequency and the body system affected, ensuring a clear, neutral communication of risk.


System-Organ Classes and Frequency

Adverse reactions are officially grouped into system-organ classes. Effects on the Immune System are central, covering a range of hypersensitivity reactions from common skin rashes to rare, serious anaphylactic shock. Gastrointestinal Disorders (diarrhea, nausea) are frequently listed, while General Disorders include common pain and inflammation at the injection site.

Serious Adverse Reactions and Systemic Risks

The official label highlights several serious adverse reactions. High concentrations of the active ingredient, often associated with renal impairment, can affect the Nervous System and lead to neurotoxicity, including seizures or convulsions. The formulation’s Procaine component can cause distinct, acute neuropsychiatric reactions (e.g., anxiety, confusion). Other serious, rare effects include severe skin reactions (SCARs) and certain blood disorders.

Safety Restrictions and Special Populations

Regulatory documentation emphasizes two critical safety constraints. First, the medicine is contraindicated in individuals with a known allergy to any penicillin or to procaine. Second, the suspension must not be administered intravenously (IV), as doing so carries a high, documented risk of severe neurovascular damage. Furthermore, patients with impaired renal function require particular consideration due to the heightened risk of drug accumulation and subsequent neurotoxicity.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdosage with Procaine Benzylpenicillin is defined by distinct toxic effects arising from both components, as outlined in regulatory documentation. High systemic concentrations of the penicillin component may result in signs of neuromuscular hyperirritability and the occurrence of convulsive seizures. Separately, the procaine component is linked to an acute toxic syndrome presenting with severe mental disturbances, including anxiety, profound confusion, and a reported fear of impending death, often accompanied by visual and auditory disturbances.

Serious or life-threatening outcomes are documented. Inadvertent intravascular administration has been reported to cause cardiorespiratory arrest and death. A critical, potentially fatal complication is Methemoglobinemia, recognized by cyanotic skin discoloration and capable of causing severe central nervous system and cardiovascular effects. Infants under 6 months of age are particularly more susceptible to this serious hematologic event.

If overdose is suspected or any severe reaction occurs, the official labeling mandates urgent intervention. Individuals must seek immediate medical attention. Regulatory guidelines specify calling emergency services right away if the individual collapses, has a seizure, or experiences trouble breathing. Management involves symptomatic and supportive treatment, as regulatory documents state that no specific antidote is known for penicillin or procaine toxicosis.

Therapeutic Uses of Depocillina

What Depocillina Treats: Main Uses and Benefits

Depocillina is commonly used to help with systemic bacterial infections and localized deep-seated soft tissue infections caused by sensitive organisms. This class of medication is intended to address certain infections caused by bacteria, including moderately severe infections of the upper respiratory tract, skin, and soft tissue. It is commonly used across conditions presenting with acute episodes, such as respiratory infections, skin conditions, and urogenital infections. This therapeutic approach is applied in addressing conditions marked by increased physiological stress, supporting the recovery process during difficult episodes by easing distress.

This medication may assist with addressing the cluster of acute symptomatic manifestations that accompany active infection, such as high fever and generalized malaise. By being used for managing the underlying cause, it contributes to easing the overall symptom burden, which helps improve day-to-day comfort during periods of illness. A key advantage is the long-acting formulation, which may be part of symptomatic management for an extended period, providing support that helps ease the overall symptom burden with fewer required interventions.

“The long-acting formula is relevant when supportive symptom management is appropriate.”

The inclusion of Procaine is relevant for easing symptoms related to physical discomfort at the injection site during administration.


Quick Fact: Relief for Acute Symptomatic Manifestations

The medication may assist with maintaining functional stability by being relevant for easing symptoms related to physical discomfort at the injection site due to its unique formulation, and supports general well-being during symptomatic phases.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who Can and Cannot Use Depocillina?

The population eligibility rules for Depocillina (Procaine Benzylpenicillin) are strictly defined by governmental regulatory documents.

Contraindicated Populations

Use is absolutely prohibited for patients with a documented history of hypersensitivity or allergic reaction to any medicine in the penicillin class or to the component procaine. The medicine is also contraindicated for those with a history of severe immediate hypersensitivity to other beta-lactam agents, such as cephalosporins.


Restricted and Conditional Use

Eligibility is limited for certain patient groups:

  • Renal Impairment: Patients with kidney disease or severe renal impairment must use the medicine with caution, as drug excretion is delayed and dosage modification is required.
  • Age Groups: Neonates and young infants require monitoring and dose adjustment due to immature kidney function. Older adults must have their renal function assessed due to age-related decline.
  • Comorbidities: Caution is required for individuals with a history of seizure disorder or epilepsy, and those with a history of allergic diathesis or asthma.
  • Pregnancy and Lactation: Use during pregnancy is conditional; safety has not been established, and use is only permitted when the benefit clearly outweighs the potential risk. The drug is excreted in human milk during lactation, and caution is advised.

What should I know about interactions with other medicines?

Depocillina Interactions with other medicines and products

This section details officially documented interaction patterns for Depocillina (Procaine Benzylpenicillin), strictly based on governmental regulatory sources. This information is non-advisory and confined to labeled constraints.


Documented Interaction Constraints

Classification Interacting Agents / Conditions
Contraindicated Combinations A history of hypersensitivity to any penicillin or to the component Procaine
Exposure-Modifying Agents Probenecid, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), and Salicylates
Pharmacodynamic Effects Hormonal Contraceptives, Aminoglycoside Antibiotics, and Methemoglobinemia-Causing Agents

Official Regulatory Notes

Co-administration with Probenecid is officially noted to interfere with renal elimination, leading to increased and prolonged plasma concentrations of Benzylpenicillin. Similar increases in serum levels may occur with NSAIDs and Salicylates. The effectiveness of hormonal contraceptives may be reduced. Due to the Procaine component, co-administration with other methemoglobinemia-causing agents increases risk. Excretion is considerably delayed in both individuals with impaired kidney function and in neonates and young infants, which is an important population-specific consideration.

Mechanism of Action

Mechanism of Irreversible Bacterial Cell Wall Disruption

The core action involves the irreversible inhibition by Benzylpenicillin of Penicillin-Binding Proteins (PBPs), a class of bacterial enzymes critical for peptidoglycan cross-linking. This mechanism initiates a lethal cascade by halting the final stage of bacterial cell wall synthesis, leading directly to the breakdown and lysis (death) of the microbial cell due to osmotic instability.


⏳ Sustained Exposure via Formulation-Driven Release

Procaine facilitates a crucial sustained-release mechanism by forming a low-solubility salt complex with the antibiotic. This complex creates a physical depot at the injection site that gradually releases active Benzylpenicillin into the circulation over time. This targeted modulation of drug absorption ensures that the cell-wall inhibition mechanism is maintained continuously over a prolonged period, supporting a sustained bactericidal exposure.


️ Local Blocking of Sensory Nerve Signals

The second function of Procaine is to exert a rapid, localized physiological effect by physically blocking voltage-gated Na^+ channels on peripheral sensory neurons. This neural blockade mechanism prevents the necessary ion influx for action potential generation, resulting in a cessation of local afferent nerve signaling.

Dosage and Administration Information

Administration Overview

Depocillina is a veterinary antibiotic preparation designed for administration via intramuscular injection. The medication consists of a suspension that requires specific handling to ensure the active ingredients are distributed evenly before use.

Preparation for Use

Before withdrawing the suspension from the vial, the container should be shaken thoroughly. This process ensures that the procaine penicillin G is properly resuspended, as the particles may settle during storage. A uniform consistency is necessary for accurate delivery.

Injection Technique

Administration is performed deep into the muscle tissue. The choice of injection site typically depends on the species being treated, following standard veterinary clinical practice for intramuscular delivery.

To prevent accidental intravenous administration, it is standard procedure to aspirate slightly with the syringe plunger before injecting the medication. If blood appears in the syringe, the needle should be withdrawn and repositioned in a different site.

Handling and Hygiene

Standard aseptic techniques should be followed throughout the preparation and administration process. This includes using sterile needles and syringes and ensuring the injection site on the animal is clean.

When multiple injections are required as part of a treatment course, it is recommended to rotate the injection sites to minimize local tissue irritation or discomfort. For large volumes, the total amount may be divided and administered at two separate sites.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Depocillina

The foundational evidence for Depocillina (Procaine Benzylpenicillin) has been studied for systemic bacterial infections and localized deep-seated soft tissue infections. Research primarily includes Randomized Controlled Trials (RCTs) and systematic reviews that compared the medicine to other treatments or control approaches. These investigations were designed to evaluate measurements related to clinical cure and the bacteriological eradication endpoint.

The studies monitored outcomes related to systemic imbalance, such as time-to-change in acute fever, and documented how symptoms evolved in the observed populations. These findings describe patterns observed regarding the resolution of the active infection over the treatment period. Patterns related to treatment response were observed in some studies only within the narrow spectrum of bacteria known to be sensitive to natural penicillins.


Evaluation of the Long-Acting Formulation

Specific Pharmacokinetic (PK) studies have been utilized to characterize the long-acting formulation containing Procaine. This research was studied to examine concentration measurements over time. These studies monitored measurements related to whether drug concentration levels remained above the minimum necessary therapeutic level during the extended period between injections. These data show patterns related to the sustained presence of the medicine in the body, which is consistent with its classification as a long-acting injectable.


Research Limitations and Uncertainty

The research landscape includes studies on various patient populations, including adults and pediatric patients. However, data for certain groups remain insufficient, and research findings apply only to the populations studied. Follow-up is primarily short-term (7 to 14 days), meaning long-term effects are not fully established, and there is limited information regarding the durability of response.

Comparative evidence is lacking against most modern antibiotic classes, and a significant portion of the core data is derived from historical investigations with relatively small sample sizes.

Frequently Asked Questions (FAQ)

Common questions about Depocillina (FAQ)

Q: What is the main difference between Depocillina and other common medicines used for the same purpose?

A: The formulation of Depocillina is a key differentiating factor. According to the official product information, it contains Procaine, which creates a depot effect at the injection site. This mechanism is designed to support the slow and sustained release of the antimicrobial agent over an extended period, contrasting with standard, short-acting penicillin salts.

Q: How long does it usually take to notice the described effects of Depocillina?

A: The long-acting formulation is designed to maintain antimicrobial levels over an extended duration. Clinical research often monitors measurements related to the overall resolution of the active infection and the time it takes for acute systemic signs, such as fever, to change during the treatment period.

Q: Are there any specific foods or drinks that should be avoided when using Depocillina?

A: Regulatory documents indicate that the timing of administration in relation to general meals or food is not specifically detailed. Any related instruction is advised to be determined by the prescribing healthcare professional. The known interactions primarily focus on other medicines that may affect the drug's levels in the body, rather than food or non-alcoholic drinks.

Q: What are the most commonly reported side effects of Depocillina?

A: Based on official documentation, common side effects are frequently reported as affecting the Gastrointestinal System, often including nausea and diarrhea. Additionally, localized reactions are common due to the injection method, often presenting as pain and inflammation at the administration site.

Q: Why is Depocillina prescribed instead of medicine X (a common alternative)?

A: The primary feature that supports the use of Depocillina is its unique long-acting nature. Official clinical pharmacology describes how the Procaine component allows it to sustain therapeutic antimicrobial concentrations in the body over an extended period, which is utilized to meet specific therapeutic needs.

Q: Is it normal to feel a change in mood or energy level while using Depocillina?

A: The Procaine component in the formulation is officially described as being associated with distinct, acute neuropsychiatric reactions. These reactions, which may include temporary instances of anxiety or confusion, are related to the systemic exposure to Procaine following administration.

Q: Is there a generic version of Depocillina available, and how does it compare?

A: The product is identified generically as Procaine Benzylpenicillin. Regulatory agencies define generic versions as being pharmaceutically equivalent to the reference product, meaning they contain the exact same active substance and are expected by regulators to perform the same way.

Q: How is the interaction with common cold and flu medicines described for Depocillina?

A: Official interaction listings identify specific over-the-counter components, such as Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Salicylates, that may affect the medicine’s concentration in the blood. These specific ingredients are often present in common cold and flu combination medicines.

Q: What happens if someone accidentally takes more Depocillina than intended?

A: Official regulatory warnings state that high levels of the active ingredient, particularly when kidney function is impaired, carry the risk of leading to neurotoxicity symptoms. This can include the risk of developing seizures or convulsions.

Q: How does the official guidance describe the need for follow-up testing while on Depocillina?

A: Regulatory guidance describes the context for monitoring certain parameters, especially during prolonged periods of therapy. This monitoring is typically used to assess renal function (kidney function, due to how the medicine is processed) and blood counts (due to potential hematologic side effects).

Q: Is it necessary to avoid alcohol completely while using Depocillina?

A: According to the official product information, there are no specific or explicit warnings mandating the complete avoidance of alcohol consumption while using this medicine.

Q: What does the official drug information say about the potential for addiction or dependence with Depocillina?

A: Official drug information addresses the potential for abuse and dependence. The documentation describes that this medicine does not have known potential for addiction or dependence.

Q: Is Depocillina known to affect fertility in men or women?

A: Regulatory text specifically addresses human fertility. It states that effects on human fertility have not been established through clinical studies.

Q: Does Depocillina impact the results of laboratory blood tests?

A: Official documentation indicates that the active ingredient, penicillin, can interfere with the results of certain laboratory tests. This includes tests for urinary proteins and some methods used to measure glucose in the urine.

Q: Can Depocillina be used to prevent certain conditions?

A: The authorized purpose of Depocillina is strictly defined as the treatment of infections caused by susceptible pathogens. Official regulatory labeling does not include prophylaxis (prevention) for any condition.

Q: Does Depocillina cause drowsiness or affect daily activities like driving?

A: Adverse reaction documentation focuses on potential effects on the Nervous System. These effects include risks of seizures and specific acute neuropsychiatric reactions (such as confusion). Therefore, official warnings describe that these systemic effects carry the potential to impact function.

Q: Does Depocillina affect blood pressure or heart rate?

A: Officially documented adverse reactions have included effects related to the heart and vasculature. These reactions, which are documented in official safety information, have included reports of hypotension (low blood pressure) and tachycardia (increased heart rate).

Q: Are there any warnings about using Depocillina before surgery or dental work?

A: Regulatory information includes warnings related to the Procaine component, which is a local anesthetic. Official warnings specify that caution should be exercised when the medicine is used in patients also receiving other methemoglobinemia-causing agents, which are sometimes used in medical or dental procedures.

How should Depocillina be stored and disposed of?

Storage and Disposal of Depocillina

Official regulatory guidelines for Procaine Benzylpenicillin Injectable Suspension (Depocillina) mandate strict storage conditions to ensure product integrity.

Mandatory Storage Conditions

Condition Requirement
Temperature Range Store in a refrigerator between 2 C and 8 C (36 F and 46 F).
Protection Must be kept from freezing and stored in the original container for light protection.
Child Safety Keep out of the sight and reach of children.

The container must be kept tightly closed. For multiple-dose formulations, the product is often required to be used within a specified period (e.g., 28 to 60 days) after the first puncture.

Disposal Instructions

Unused or expired medicine must be disposed of in accordance with local regulations and is strictly prohibited from being released into the environment, such as through the sewage system or wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Depocillina found in:

A-Z Index: